Viewing Study NCT05803395


Ignite Creation Date: 2025-12-24 @ 1:29 PM
Ignite Modification Date: 2026-06-02 @ 7:56 PM
Study NCT ID: NCT05803395
Status: UNKNOWN
Last Update Posted: 2023-11-28
First Post: 2023-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None Indolent B-Cell Non-Hodgkin Lymphoma View
None COVID-19 View
Keywords: